Cargando…
Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas
Interleukin-1 alpha (IL-1α) is a pleiotropic cytokine involved in inflammation and immune response and is upregulated in many solid tumors including head and neck squamous cell carcinomas. Although IL-1α expression is generally associated with poor prognosis, the implications of the subcellular loca...
Autores principales: | Rajan, Anand, Gibson-Corley, Katherine N., Choi, Allen B., Ofori-Amanfo, Georgina K., Ten Eyck, Patrick, Espinosa-Cotton, Madelyn, Sperry, Steven M., Simons, Andrean L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607721/ https://www.ncbi.nlm.nih.gov/pubmed/31320902 http://dx.doi.org/10.1155/2019/5859680 |
Ejemplares similares
-
Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
por: Wongpattaraworakul, Wattawan, et al.
Publicado: (2022) -
Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2019) -
Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
por: Stanam, Aditya, et al.
Publicado: (2016) -
A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2019) -
Characterization of CPH:SA microparticle‐based delivery of interleukin‐1 alpha for cancer immunotherapy
por: Hasibuzzaman, M. M., et al.
Publicado: (2022)